{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T14:29:12Z","timestamp":1786631352213,"version":"build-2736575974"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12475-6","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T13:36:33Z","timestamp":1786628193000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["DBF4B promotes hepatocellular carcinoma progression by regulating CCNA2 and PSMD11 expression"],"prefix":"10.1007","volume":"53","author":[{"given":"Bing","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengju","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangxin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqi","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenming","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"key":"12475_CR1","doi-asserted-by":"publisher","unstructured":"Foglia B, Turato C, Cannito S (2023) Hepatocellular Carcinoma: Latest Research in Pathogenesis, Detection and Treatment, (in eng), International journal of molecular sciences, vol. 24, no. 15, Jul 31 https:\/\/doi.org\/10.3390\/ijms241512224","DOI":"10.3390\/ijms241512224"},{"key":"12475_CR2","doi-asserted-by":"publisher","unstructured":"Ganesan P, Kulik LM (2023) Hepatocellular Carcinoma: New Developments, (in eng), Clinics in liver disease, vol. 27, no. 1, pp. 85\u2013102, Feb https:\/\/doi.org\/10.1016\/j.cld.2022.08.004","DOI":"10.1016\/j.cld.2022.08.004"},{"key":"12475_CR3","doi-asserted-by":"publisher","unstructured":"Sugawara Y, Hibi T Surgical treatment of hepatocellular carcinoma, (in eng), Bioscience trends, vol. 15, no. 3, pp. 138\u2013141, Jul 6 2021. https:\/\/doi.org\/10.5582\/bst.2021.01094","DOI":"10.5582\/bst.2021.01094"},{"key":"12475_CR4","doi-asserted-by":"publisher","unstructured":"Zhou H, Song T (2021) Conversion therapy and maintenance therapy for primary hepatocellular carcinoma, (in eng), Bioscience trends, vol. 15, no. 3, pp. 155\u2013160, Jul 6 https:\/\/doi.org\/10.5582\/bst.2021.01091","DOI":"10.5582\/bst.2021.01091"},{"key":"12475_CR5","doi-asserted-by":"publisher","unstructured":"Wang Z, Qin H, Liu S, Sheng J, Zhang X (May 20 2023) Precision diagnosis of hepatocellular carcinoma, (in eng). Chin Med J 136(10):1155\u20131165. https:\/\/doi.org\/10.1097\/cm9.0000000000002641","DOI":"10.1097\/cm9.0000000000002641"},{"key":"12475_CR6","doi-asserted-by":"publisher","unstructured":"Renne SL et al (2021) Hepatocellular carcinoma: a clinical and pathological overview, (in eng), Pathologica, vol. 113, no. 3, pp. 203\u2013217, Jun https:\/\/doi.org\/10.32074\/1591-951x-295","DOI":"10.32074\/1591-951x-295"},{"key":"12475_CR7","doi-asserted-by":"publisher","unstructured":"Tsuji T, Lau E, Chiang GG, Jiang W The role of Dbf4\/Drf1-dependent kinase Cdc7 in DNA-damage checkpoint control, (in eng), Molecular cell, vol. 32, no. 6, pp. 862\u20139, Dec 26 2008. https:\/\/doi.org\/10.1016\/j.molcel.2008.12.005","DOI":"10.1016\/j.molcel.2008.12.005"},{"key":"12475_CR8","doi-asserted-by":"publisher","unstructured":"Takahashi TS, Basu A, Bermudez V, Hurwitz J, Walter JC Cdc7-Drf1 kinase links chromosome cohesion to the initiation of DNA replication in Xenopus egg extracts, (in eng), Genes & development, vol. 22, no. 14, pp. 1894\u2013905, Jul 15 2008. https:\/\/doi.org\/10.1101\/gad.1683308","DOI":"10.1101\/gad.1683308"},{"key":"12475_CR9","doi-asserted-by":"publisher","unstructured":"Qin C et al (2025) Pan-cancer analysis identifies DBF4B as an immunologic and prognostic biomarker, (in eng), Journal of Cancer, vol. 16, no. 8, pp. 2626\u20132648. https:\/\/doi.org\/10.7150\/jca.109134","DOI":"10.7150\/jca.109134"},{"key":"12475_CR10","doi-asserted-by":"publisher","unstructured":"Wang Y, Deng B (2023) Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers, (in eng), Cancer metastasis reviews, vol. 42, no. 3, pp. 629\u2013652, Sep https:\/\/doi.org\/10.1007\/s10555-023-10084-4","DOI":"10.1007\/s10555-023-10084-4"},{"key":"12475_CR11","doi-asserted-by":"publisher","unstructured":"Zhou T et al (2021) DTYMK promote hepatocellular carcinoma proliferation by regulating cell cycle, (in eng), Cell cycle (Georgetown, Tex.), vol. 20, no. 17, pp. 1681\u20131691, Sep https:\/\/doi.org\/10.1080\/15384101.2021.1958502","DOI":"10.1080\/15384101.2021.1958502"},{"key":"12475_CR12","doi-asserted-by":"publisher","unstructured":"Sun J et al (2022) DNASE1L3 inhibits hepatocellular carcinoma by delaying cell cycle progression through CDK2, (in eng), Cellular oncology (Dordrecht, Netherlands), vol. 45, no. 6, pp. 1187\u20131202, Dec https:\/\/doi.org\/10.1007\/s13402-022-00709-1","DOI":"10.1007\/s13402-022-00709-1"},{"key":"12475_CR13","doi-asserted-by":"publisher","unstructured":"Qu M et al (Jan 10 2023) Circadian regulator BMAL1::CLOCK promotes cell proliferation in hepatocellular carcinoma by controlling apoptosis and cell cycle, (in eng). Proc Natl Acad Sci U S A 120(2):e2214829120. https:\/\/doi.org\/10.1073\/pnas.2214829120","DOI":"10.1073\/pnas.2214829120"},{"key":"12475_CR14","doi-asserted-by":"publisher","unstructured":"Silva T, Bradley RH, Gao Y, Coue M (Apr 28 2006) Xenopus CDC7\/DRF1 complex is required for the initiation of DNA replication, (in eng). J Biol Chem 281(17):11569\u201311576. https:\/\/doi.org\/10.1074\/jbc.M510278200","DOI":"10.1074\/jbc.M510278200"},{"key":"12475_CR15","doi-asserted-by":"publisher","unstructured":"Zhou HY et al (May 2024) CCNA2 and NEK2 regulate glioblastoma progression by targeting the cell cycle, (in eng). Oncol Lett 27(5):206. https:\/\/doi.org\/10.3892\/ol.2024.14339","DOI":"10.3892\/ol.2024.14339"},{"key":"12475_CR16","doi-asserted-by":"publisher","unstructured":"Wang T et al (2024) Construction of a prognostic model based on disulfidptosis-related genes and identification of CCNA2 as a novel biomarker for hepatocellular carcinoma, (in eng), Biology direct, vol. 19, no. 1, p. 128, Dec 19 https:\/\/doi.org\/10.1186\/s13062-024-00569-9","DOI":"10.1186\/s13062-024-00569-9"},{"key":"12475_CR17","doi-asserted-by":"publisher","unstructured":"Wei H, Li J, Li Y, Song J (Oct 30 2019) MicroRNA-451 inhibits inflammation and proliferation of glomerular mesangial cells through down-regulating PSMD11 and NF-\u03baB p65, (in eng). Biosci Rep 39(10). https:\/\/doi.org\/10.1042\/bsr20191455","DOI":"10.1042\/bsr20191455"},{"key":"12475_CR18","doi-asserted-by":"publisher","unstructured":"Maltseva DV, Raigorodskaya MP, Tikhonova OV, Knyazev EN, Tonevitsky EA (2020) Relationship between the Expression Level of PSMD11 and Other Proteasome Proteins with the Activity of Ricin and Viscumin, (in eng), Doklady. Biochemistry and biophysics, vol. 493, no. 1, pp. 198\u2013200, Jul https:\/\/doi.org\/10.1134\/s1607672920040080","DOI":"10.1134\/s1607672920040080"},{"key":"12475_CR19","doi-asserted-by":"publisher","unstructured":"Zhou C et al (2022) Prognostic Value and Molecular Mechanisms of Proteasome 26S Subunit, Non-ATPase Family Genes for Pancreatic Ductal Adenocarcinoma Patients after Pancreaticoduodenectomy, (in eng), Journal of investigative surgery: the official journal of the Academy of Surgical Research, vol. 35, no. 2, pp. 330\u2013346, Feb https:\/\/doi.org\/10.1080\/08941939.2020.1863527","DOI":"10.1080\/08941939.2020.1863527"},{"key":"12475_CR20","doi-asserted-by":"publisher","unstructured":"Sun L et al (Sep 2024) PSMD11 promotes the proliferation of hepatocellular carcinoma by regulating the ubiquitination degradation of CDK4, (in eng). Cell Signal 121:111279. https:\/\/doi.org\/10.1016\/j.cellsig.2024.111279","DOI":"10.1016\/j.cellsig.2024.111279"},{"key":"12475_CR21","doi-asserted-by":"publisher","unstructured":"Cooney JD et al (2018) Synergistic Targeting of the Regulatory and Catalytic Subunits of PI3K\u03b4 in Mature B-cell Malignancies, (in eng), Clin Cancer Res, vol. 24, no. 5, pp. 1103\u20131113, Mar 1 https:\/\/doi.org\/10.1158\/1078-0432.Ccr-17-2218","DOI":"10.1158\/1078-0432.Ccr-17-2218"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12475-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12475-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12475-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T13:36:33Z","timestamp":1786628193000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12475-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12475"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12475-6","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,13]]},"assertion":[{"value":"13 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have not disclosed any competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The TMA used in this study was purchased from Shanghai Outdo Biotech Co., Ltd. (Array No.: HLivH169Su01), and its use was approved by the Ethics Committee of Shanghai Outdo Biotech Co., Ltd. (approval no. SHXC2021YF01). All animal experiments were approved by the Institutional Animal Care and Use Committee of Shanghai Tenth People\u2019s Hospital Tongji University (ID number: SHDSYY-2026-1433) and reported in accordance with ARRIVE guidelines.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Patient consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1398"}}